
Last year for us, like all Ukrainians, was a daily test for stability and loyalty to a common idea. We each received a unique experience of restructuring processes and organizing work in new realities. From the very first days of the full-scale invasion, we began to resume manufacturing activities. Logistics is the most critical issue…
After massive missile strikes that destroyed critical infrastructure, we faced the need to reduce electricity consumption in order to save power in the unified energy system of Ukraine. At the same time, it was critically important for us to release the planned volume of products. We were preparing for different scenarios, the starting point for…
July 9 is the anniversary of the founding of the Ukrainian pharmaceutical group YURіA-PHARM. It was thirty-two years ago that the business was founded, which grew, developed and changed together with Ukraine. During this time, we have experienced many trials, but we have never had to work during a war. War. In the early days,…
The war mobilized and rallied domestic pharmaceutical companies to selfless work 24/7. We all understand what an important duty is entrusted to us: to support the defense capability of our country, providing the health care system and military medicine with the necessary medicines. Today, YURіА-PHARM has focused on two directions – production and distribution. Production….
Umerox® Ingal is an individual device designed for inhalation of methoxyflurane. Methoxyflurane, solution for inhalation, 2 ml administered through the Yumerox® Ingal inhaler is a fast-acting, inhalable and non-narcotic analgesic. Indications for the use of Methoxyflurane are emergency relief of moderate to severe pain in adult patients with trauma who are conscious. Аnesthesia for short-term treatment…